Objective. Osteoarthritis (OA), a chronic degenerative joint disorder, is characterized by joint pain. Emerging research demonstrates that a significant number of patients evidence central sensitization (CS), a hyperexcitability in nociceptive pathways, which is known to amplify and maintain clinical pain. The clinical correlates of CS in OA, however, are poorly understood. Insomnia is prevalent in older adults with OA, and recent experiments suggest associations between poor sleep and measures of CS. Catastrophizing, a potent predictor of pain outcomes, has also been associated with CS, but few studies have investigated possible interactions between catastrophizing, sleep, and CS. Methods. We conducted a case-control study of 4 well-characterized groups of adults with insomnia and/or knee OA. A total of 208 participants completed multimodal sleep assessments (questionnaire, diary, actigraphy, and polysomnography) and extensive evaluation of pain using clinical measures and quantitative sensory testing to evaluate associations between CS, catastrophizing, and insomnia. Descriptive characterization of each measure is presented, with specific focus on sleep efficiency and CS. Results. The knee OA-insomnia group demonstrated the greatest degree of CS compared to controls. In the overall sample, we found that catastrophizing moderated the relationship between sleep efficiency and CS. Specifically those with low sleep efficiency and high catastrophizing scores reported increased levels of CS. In addition, CS was significantly associated with increased clinical pain. Conclusion. These findings highlight the importance of assessing sleep efficiency, CS, and catastrophizing in chronic pain patients and have important clinical implications for treatment planning.
INTRODUCTION
Pain is the most common symptom of knee osteoarthritis (OA), a degenerative joint disease that is characterized by loss of cartilage in the knee, development of osteophytes, and mobility limitation. Knee OA is one of the leading causes of pain and disability worldwide, affecting approximately one-third of older adults (1, 2) . A growing literature has documented augmented central nervous system (CNS) processing in OA. In animal models, central sensitization (CS) is demonstrated as aberrant heightened spinal and supraspinal processing that increases afferent nociceptive input. Clinically it manifests as hypersensitivity to pain that sometimes spreads beyond peripheral generators and is a marker for pain chronification (3, 4) . CS can be assessed through the application of noxious stimuli (e.g., temporal summation or pain aftersensations) (3) . Both animal models and human laboratory and imaging studies have implicated CS of nociceptive pathways as a mechanism of clinical pain amplification in OA (5) . Recent work from our group found substantial discordance between clinical pain reports and radiographic evidence of OA in knee OA patients (e.g., increased reports of clinical pain were not corroborated by radiographic evidence of cartilage loss in OA). Patients with a high degree of clinical pain but minimal to mild radiographic evidence of joint disease exhibited greater CS, and conversely, patients reporting low clinical pain with moderate to severe radiographic evidence demonstrated reduced CS (6) .
Sleep disturbance has become recognized as an important factor in determining pain perception. Systems that regulate both arousal and pain are neurobiologically intertwined and may share common pathways (7) . Sleep disruption in healthy individuals amplifies pain perception (8) and is associated with increased pain sensitivity and disability in chronic pain patients (9) . Sleep disturbance also increases risk for developing pain (10) , and disrupted sleep following painful injury is associated with developing persistent postinjury pain (11) .
Insomnia, defined as a subjective report of problems initiating or maintaining sleep, or nonrestorative sleep, is the most common sleep disorder, and similar to knee OA, has increased prevalence in later life, as almost 50% of older adults report insomnia (7) . Further, knee OA and insomnia frequently co-occur, and more than 50% of patients with OA experience significant disturbances initiating or maintaining sleep (12) . A relationship between sleep disturbance and pain severity in OA patients is consistently observed, and sleep disturbances such as shortened sleep duration and fragmented sleep (12) have been specifically hypothesized to have direct effects on hyperalgesia in OA patients (13) . Polysomnography (PSG), the gold standard sleep measure, has been applied in only a few small studies of knee OA. Large multimodal evaluations of sleep using PSG, self-report, and other measures of sleep are needed to better characterize and determine associations between sleep parameters, CS, and pain in knee OA.
Catastrophizing, a persistently negative cognitive affective style characterized by helplessness, magnification, and ruminative thoughts regarding one's pain, is a potent predictor of negative pain-related outcomes in general (14) and OA pain specifically (15) . Catastrophizing has been linked to both sleep disturbance (16) and indices of CS (17, 18) . Little empirical work has focused on the combined effects of catastrophizing and sleep disturbance on pain or CS, despite the fact that interventions designed to reduce presleep pain-related catastrophizing cognitions are actively being tested in patients with comorbid insomnia and chronic pain (see reference 19 for review).
The current study sought to characterize sleep and pain and their association in knee OA patients with and without insomnia versus matched controls with and without insomnia. This characterization was accomplished by employing multimodal evaluation of sleep using PSG, actigraphy, sleep questionnaires, and diary measures, and evaluation of pain using clinical measures and quantitative sensory testing (QST). With respect to sleep-related measures, we hypothesized that knee OA-insomnia (knee OA-I) patients would exhibit objectively worse sleep efficiency than insomnia patients without knee OA and goodsleeping subjects. With respect to pain-related measures, we hypothesized that knee OA-I patients would evidence greater clinical pain as well as greater CS than goodsleeping knee OA patients and non-knee OA controls. To reduce the number of comparisons presented and the potential for family-related error, we present descriptive information for all variables and have only conducted statistical analyses on our measures of specific interest: sleep efficiency, CS, and questionnaires. Of all of the sleep and pain variables we measured, sleep efficiency and CS were chosen because they are the strongest summary measures representing the overall quality of sleep continuity and hypersensitivity to pain.
In addition to the primary aims, we also explored the extent to which pain catastrophizing mediated the association of subjective sleep efficiency, which has welldocumented associations with clinical and laboratory pain (20) as well as catastrophic thinking (14, 21) and CS across subjects. The diary measure of sleep efficiency was chosen because it is widely used and well validated in older adults (22) and represents individuals' perception of their own sleep.
MATERIALS AND METHODS
The current case-control study is the first phase of a project that involves a randomized controlled trial of cognitive behavioral therapy for insomnia in OA. Participants were recruited via advertisements in community media outlets and physician offices. A total of 208 participants (72.1% women) were included in the current analyses. Participants were categorized into 4 groups based on diagnostic eligibility criteria: 1) OA patients meeting research diagnostic criteria (RDC) for insomnia disorder (23) (knee OA-I; n 5 118), 2) OA patients meeting RDC criteria for normal sleep (knee OA; n 5 31), 3) healthy controls meeting RDC criteria for primary insomnia (PI; n 5 30), and 4) healthy controls without a pain syndrome, meeting RDC criteria for normal sleep (controls; n 5 29). Knee OA groups were matched on radiographic evidence of disease severity (Kellgren/Lawrence scale) (24) .
For inclusion in the knee OA groups, all participants met the American College of Rheumatology criteria (25) , based on history and physical examination, bilateral standing, and semiflexion-view radiographs, diagnosed by a board-certified rheumatologist, had at least 1 knee rated at least 1 on the Kellgren/Lawrence scale for radiographic
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Campbell et al assessment of joint damage, had knee pain .2 of 10 on a near daily basis (.4 days/week) for $6 months prior to entering the study, were not scheduled for arthroplasty during the study period, and (for those taking medications) maintained a stable dose for $1 month prior to starting the study. For inclusion in the insomnia groups, participants were further examined and categorized based on the Structured Interview for Sleep Disorders (26) to confirm that subjects met both the American Academy of Sleep Medicine RDC (23) and the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria for insomnia disorder. Additional sleep criteria included report of either latency to sleep onset .30 minutes, $2 awakenings/night of .15 minutes duration, or wake after sleep onset (WASO) time .30 minutes, as well as insomnia symptom frequency $3 nights/week for $1 month. For inclusion in the normal sleeper group, participants were required to meet RDC insomnia criteria for normal sleepers and to have a Pittsburgh Sleep Quality Index score ,5. Criteria for normal sleepers were required at intake, retrospectively, and as an average profile (2 weeks of baseline diaries) (27) .
Healthy control participants were required to be free from any acute pain, injury, or history of chronic pain in the past 3 years (pain severity report .2 of 10, .2 days/ week for 6 months excluded) and to report good overall health with no unstable major medical or psychiatric illness. General exclusion criteria, applied to all groups, included 1) having a serious medical illness, such as congestive heart disease, history of cerebral vascular accidents, cancer, and other chronic pain or rheumatic disorders, 2) having severe or unstable psychopathology or cognitive impairment/dementia, and 3) having a current or recent history (within 6 months) of substance abuse disorder (or positive toxicology screening) or major medical illness. Participants were also excluded if they were found to have any untreated sleep disorders other than insomnia (e.g., obstructive sleep apnea, periodic limb movement disorder, and apnea hypopnea index score .15). Participants agreed to discontinue all pain-relieving and sedative medications 24 hours prior to the QST session.
Procedures. All participants completed informed consent procedures and were administered a clinical examination/interview, self-report questionnaires (Western Ontario and McMaster Universities Osteoarthritis Index [WOMAC] [28] , Pain Catastrophizing Scale [29] , and Center for Epidemiologic Studies Depression Scale [30] ), sleep assessments (Pittsburgh Sleep Quality Index [31] , Insomnia Severity Index [32] , Epworth Sleepiness Scale [33] , electronic sleep diaries, actigraphy, and in-home, ambulatory overnight PSG), electronic pain diary (similar to the Brief Pain Inventory) (34) , and a series of quantitative sensory tests (described below). For those included in the knee OA groups, bilateral knee radiographs were performed as well as a knee examination conducted by a rheumatologist, as previously described (6) . The clinical interview included use of the Structured Interview for Sleep Disorders (26) , according to the DSM-IV-TR (35) , which demonstrates sound reliability and validity based on PSG and expert interviews. The interview generated current and lifetime DSM-IV-TR axis-I and axis-III sleep disorder diagnoses. Axis-III diagnoses such as obstructive sleep apnea were considered provisional until confirmed by the sleep laboratory findings.
Sleep assessments. Diaries. A sleep diary was completed on a Palm Pilot personal digital assistant (PDA; Tungsten E2); specifically, participants entered the time they went to bed, latency to sleep onset, WASO, final awakening, and time out of bed each morning for 2 weeks to create indices of sleep continuity.
Wrist actigraphy. Actigraphs are watch-like devices worn on the nondominant wrist that continuously track movements. Participants were trained in wrist actigraphy monitoring and wore an Actigraph 2 (Philips Healthcare/ Respironics) for 2 weeks while completing diaries to provide an objective index of sleep efficiency and latency, WASO, and total sleep time (TST) (36) . Data were collected in 60-second intervals with medium sensitivity. We used a PSG-validated algorithm to estimate sleep continuity parameters (37) .
PSG. Following completion of actigraphy, participants underwent a 1-night (38) , in-home, ambulatory overnight PSG sleep study with demonstrated reliability (39), fully described by the Sleep Heart Health Study (40) . Two highly trained PSG technicians used standard procedures to obtain the recording montage, using normal placement of electrocardiography, electrooculography, and electromyography (41) . PSG was scored in 30-second intervals according to standard Rechtschaffen and Kales criteria (41) . A subset (10%) of all the records from the project was rescored to assess interrater agreement.
QST. Pain threshold. Heat-pain threshold (HPT) was assessed via a Peltier-element-based stimulator (Medoc Pathway Advanced Thermal Stimulator), on the nondominant ventral forearm and the patella of the index knee, with a 9-cm 2 probe, using an ascending method of limits paradigm with a 0.58C/second rate of rise. Pressure-pain threshold (PPT) was assessed via algometer (SBmedic, 1 cm 2 hard rubber probe) 2 times at the trapezius muscle (bilateral), and the insertion point of the quadriceps (index knee) according to standard procedures (42) . Mean values for HPT (in 8C) and PPT (in kilopascals) were averaged across trials.
Temporal summation. Thermal temporal summation (TTS) was assessed via response to 3 series, each of 10 heat pulses of equal temperature rated on a 0-100 scale (temperatures: one using a tailored temperature [designed to be moderately painful], one at 498C, and one at 518C, in random order), applied to the left dorsal forearm (Medoc Pathway Contact Heat-Evoked Potential Stimulator) (43) . A 2.5 second interstimulus interval and a 708C/second rate of rise were employed. A TTS difference score (maximal rated pulse of the series minus first pulse of the series) was created for each temperature. One additional pain rating was obtained 15 seconds following the final pulse in each series to characterize aftersensations. Mechanical temporal summation (MTS) was assessed at 2 weights via response to an initial single stimulus, followed by a sequence of 10 stimuli of identically weighted punctate probes applied on a flat contact area of 0.2 mm diameter with a force of 256 mN and 512 mN, to the middle phalanx, dorsal surface of the nondominant middle finger, and the patella of the index knee (randomly assigned for non-OA patients). Each series was delivered with an interstimulus interval of 1 second, and participants were instructed to rate the peak pain experienced over the train of 10 stimuli. An MTS difference score was calculated (peak rating minus initial stimulus rating) for each probe weight. Similar procedures assessing responses to repetitive suprathreshold noxious stimuli as an index of CS have been previously employed in a variety of subjects (44) .
Cold pressor. Pain ratings were additionally assessed using cold pressor testing (CPT). Participants immersed the nondominant hand in a circulating water bath maintained at 48C. A total of 4 immersions lasting a maximum of 45 seconds were conducted. Participants were permitted to remove their hand prior to the completion of the trial if the pain became intolerable. Pain ratings on a 0-100 scale were obtained at 20 seconds, then when participants removed their hand from the water bath, and (to characterize aftersensations) additionally at 30 seconds, 1 minute, and 2 minutes after hand removal. Pain ratings were averaged across the 4 trials.
Conditioned pain modulation (CPM). Two baseline PPT readings were obtained on the dominant side trapezius muscle immediately prior to beginning the CPT. Then at the 20-second point during each of the hand immersion trials for CPT, a PPT reading was obtained on the contralateral trapezius muscle. A difference value was created for CPM by averaging the 2 PPT values obtained during the CPT trials, and the average of the 2 baseline PPT readings was subtracted from the trial average (to yield a positive number if threshold increased during hand immersion).
All QST methods were given Z scores separately, reversed where appropriate, and combined to establish one sensitivity index, as previously described (45), where higher values represent greater sensitivity. Similarly, TTS, MTS, CPM, and aftersensation Z scores were combined to create one measure of CS, which was the primary QSTderived variable of interest. Of note, difference scores were computed as opposed to index scores (for TTS, MTS, and CPM), because creating index scores would have created missing data for subjects (in those with no baseline pain, by attempting to divide by 0); this would have primarily been problematic for MTS. We chose to keep this calculation consistent and use a difference score for all variables requiring such computation.
Statistical analysis. All analyses were conducted using SPSS software, version 20. Chi-square tests were used to compare categorical demographic variables between the participant groups. To reduce multiple comparisons, a series of analyses of variance, to examine group differences, was only conducted on measures of sleep efficiency, CS (obtained from laboratory pain responses to specific tests), and questionnaires of interest. Pearson's product-moment correlations were calculated to examine the relationship between these variables. In addition, differences between objectively (actigraphy) and subjectively (PDA) reported sleep were evaluated within-night for each person. Pain testing measures thought to reflect CS were given Z scores and combined to create an index. The CS measure included TTS, MTS, CPM (CPM was reversed [multiplied by 21] to make the direction of sensitivity consistent and comparable across tests), and aftersensations to TTS and cold water hand immersion. A general QST sensitivity index was also created that combined every QST measure (reversed where appropriate). Planned contrasts were conducted to compare the CS variable between each group.
Hayes' (46) PROCESS macro was employed to examine the potential moderating effect of catastrophizing on the relationship between sleep and CS. An ordinary least squares or logistic regression-based path analytical framework was employed in this macro to analyze statistical models. Model 1, for moderation, was used in the current analyses. Age was entered as a covariate to control for potential demographic confounding.
RESULTS
Patient demographics and clinical characteristics for each group are shown in Table 1 . All demographic characteristics of the sample were roughly equivalent between groups with the exception of age. The knee OA group was significantly older than each of the other groups (P , 0.001 for all). Self-reported clinical measures varied by group in a generally predictable manner, with those in the knee OA-I group generally exhibiting the highest pain (measured by WOMAC), depression, catastrophizing, and body mass index. Participants in the PI group also exhibited elevated depressive symptoms and had the poorest sleep quality (measured by the Pittsburgh Sleep Quality Index). In the entire sample, clinical pain report was significantly associated with each sleep questionnaire (r 5 0.3-0.4, P , 0.001 for all), catastrophizing (r 5 0.48, P , 0.001), depression (r 5 0.32, P , 0.001), diary sleep efficiency (r 5 20.32, P , 0.001), and the CS measure (r 5 0.32, P , 0.001). Diary sleep efficiency was correlated with each measure (r 5 20.22 to 20.70, P , 0.04 for all). Additionally, the CS measure was correlated with all variables (r 5 20.22 to 0.32, P , 0.02 for all), other than sleepiness (Epworth Sleepiness Scale).
Sleep. Measures of sleep continuity by measurement method, sleep architecture, and clinical sleep disorder indices are shown in Table 2 . The pattern of findings in sleep continuity measures appears to depend on assessment method. The knee OA-I group demonstrated greater sleep discontinuity as measured by diminished sleep efficiency on diary, actigraphy, and PSG measures. Both insomnia groups reported significantly lower sleep efficiency when compared to both noninsomnia groups (P , 0.001) on their sleep diaries. Knee OA-I participants also experienced reduced sleep efficiency measured by actigraphy compared to healthy controls and, surprisingly, PI participants. Knee OA-I participants also had reduced sleep efficiency compared to controls on PSG. Controlling for age did not alter significance. TST, sleep latency, and WASO in the insomnia groups all appeared worse than good-sleeping groups on diary measures. However, patterns appeared more inconsistent for actigraphy and PSG. Interestingly, on both actigraphy and PSG measures of TST, all 4 groups demonstrated low TST that appeared nearly equivalent. The largest within-night differences between objective and subjective sleep measures were observed primarily in the knee OA group. This group was observed to have the greatest difference between objective and subjective measures for sleep efficiency (21% worse observed in actigraphy compared to PDA report), TST (108 more minutes of sleep reported in PDA), and WASO (102 fewer minutes of sleep reported in PDA). The PI group had the largest difference for sleep onset latency, believing it took on average 30 minutes longer to fall asleep (reported in PDA) than indicated by actigraphy. Sleep architecture and clinical sleep disorder indices were comparable between groups, except for periodic limb movement, which appeared substantially greater among the knee OA-I group compared to controls.
Group differences for QST. Laboratory pain measures are displayed for each group in Table 3 . Additionally, Z-scored values, to make laboratory measures with different response scales comparable, are shown in Figure 1 . A significant difference was observed between groups on the CS measure, our primary QST measure of interest, with knee OA-I patients being the most sensitive (P 5 0.01). Specifically, they were significantly more sensitive when compared to healthy controls (P 5 0.002) and marginally so when compared with PI patients (P 5 0.06). Identical significance levels were observed when controlling for age. The QST index appeared to differ between groups, again with knee OA-I patients being the most sensitive. With regard to individual laboratory tests, only PPT at the index knee and both aftersensations appeared different between groups, with the knee OA-I group being most sensitive. Surprisingly, for PPT at the knee, the PI group appeared to be the least pain sensitive of all the groups.
Moderation analysis. Catastrophizing was significantly associated with CS, and greater catastrophizing was associated with higher levels of CS (b 5 0.009, P 5 0.02). Sleep efficiency (measured by diary and averaged over the assessment period) was significantly associated with CS (b 20.80, P 5 0.003). A significant interaction emerged between catastrophizing and sleep efficiency (b 20.07, P 5 0.007). This interaction is shown in Figure 2 , which depicts the simple slope of sleep efficiency for low (SD 21) and high (SD 1) catastrophizing. Simple slopes were tested across levels of sleep efficiency and only low sleep efficiency revealed a sig- (25) . ‡ P , 0.001 by 2-tailed t-test, different from control and from knee OA good sleeper. § P , 0.001 by 2-tailed t-test. ¶ P , 0.05 by 2-tailed t-test, different from control and from primary insomnia (no knee OA). # P , 0.05 by 2-tailed t-test. ** P , 0.01 by 2-tailed t-test, different from control. † † 0.05 , P , 0.10 by 2-tailed t-test.
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Campbell et al nificant association between catastrophizing and CS (b 5 0.02, P 5 0.0001). When controlling for clinical pain, as well as sex, the pattern of significance does not change. We probed the interaction further by use of the JohnsonNeyman technique (46) to evaluate the regions of significance of the conditional effect. This evaluation allows for visualization of the range of values within the moderator where the interaction is significant. Figure 3 plots the conditional effect of sleep efficiency on CS across values of catastrophizing. The region of significance lies where the confidence interval does not include 0. Thus, sleep efficiency is associated with CS when catastrophizing is .7.4. Participants with catastrophizing scores .7.4 accounted for 56.3% (n 5 116) of the sample (2 participants were missing Pain Catastrophizing Scale scores). While only 22-33% of participants in each group (controls, n 5 9; knee OA, n 5 7; PI, n 5 10) experienced catastrophizing above this level, it represented 77% of the knee OA-I patients (n 5 90).
DISCUSSION
To our knowledge, this is the largest multimodal sleep study in knee OA patients to date and the only one to use in-home measures. Knee OA-I showed strong evidence of sleep continuity disturbance measured across multiple modalities. These findings suggest various differences between knee OA patients with and without insomnia versus controls with and without insomnia in terms of sleep parameters, psychological factors, clinical pain, and laboratory pain sensitivity. Participants in our study's 2 insomnia groups varied in subjective versus objectively determined sleep parameters. Such discordance is not unusual in the larger literature (47) . However, the noninsomnia groups (controls and, particularly, knee OA participants without insomnia) overestimated their sleep efficiency and TST and underestimated their WASO. Participants in the PI group overestimated their sleep onset latency by approximately 30 minutes per night when compared with actigraphy. Additionally, we observed evidence of high rates of periodic limb movement in participants with knee OA. One other report has suggested a relationship between OA and excessive night-time movement (48) ; however, these data should be examined in light of their potential contribution to sleep difficulty and contribution to pain in OA patients. While we were underpowered to fully examine all possible data described, we hope these data serve as a platform for future studies that can be adequately powered and explore potential differences. Catastrophizing is an increasingly recognized factor influencing clinical pain in OA patients (15) . Several reports have found a relationship between catastrophizing and temporal summation of pain, a marker of CS (17, 18) . A number of published reports have documented the relationship between poor/disturbed sleep and hyperalgesia (7, 20) . In addition, 1 study by members of our group found that a significant proportion of variance in clinical pain severity and pain-related interference attributable to pain catastrophizing was actually mediated by sleep disturbance in a facial pain population (16) . Catastrophizing, sleep efficiency, and an interaction between sleep efficiency and catastrophizing significantly mediates the severity of CS in participants. These results provide preliminary evidence in support of a combined effect of catastrophizing and sleep, resulting in increased pain sensitivity in OA. CS has been hypothesized to account for the hypersensitivity observed in a number of chronic pain conditions (3). Support for this theory has been evidenced by enhanced temporal summation, aftersensations, secondary hyperalgesia, and/or tactile allodynia among patients with various conditions, including OA and rheumatoid arthritis, temporomandibular joint disorder, fibromyalgia, headache, neuropathic pain, chronic musculoskeletal pain, and chronic visceral pain (3).
Not surprisingly, clinical pain differed between groups. In terms of laboratory pain measures, enhanced CS was primarily observed in the knee OA-I group. This observation suggests that insomnia in knee OA might be an easily identified clinical marker for the possibility of CS. This marker could be used clinically to conduct formal testing or may hint that central pain agents may be useful in treating OA hyperalgesia. Of note, neither clinical pain nor sex, both factors known to be associated with CS, impacted the interaction between sleep and catastrophizing on CS. Clinical implications of these findings suggest that treatment options for OA patients could include sleep and/or intervention for catastrophizing, both modifiable risk factors that may aid in reducing CS and decreasing clinical pain. A recent study found that a cognitive behavioral therapy intervention to reduce catastrophizing was effective in OA patients scheduled for total knee replacement (49) .
Relative to controls, OA patients exhibit greater pain sensitivity across a variety of anatomical sites, including both affected and nonaffected tissues (5) . Contrary to our findings, recent work has indicated that knee OA patients rate suprathreshold mechanical stimuli on the upper body as more intensely painful than controls (50). However, knee OA patients in our study reported enhanced sensitivity to PPTs on the knee. Most published knee OA reports are based on findings of reduced pain threshold or tolerance, measures that do not provide information about abnormalities in CS or CNS pain modulatory processes. The measures used in the current study to examine CS included TTS, MTS, CPM, and aftersensations. These are well-established markers for CS, assess central pain modulation (3), and may be more robustly linked with clinical pain (51) . Clinical pain report was significantly associated with the CS measure, as was body mass index, depression, insomnia, and catastrophizing. The aftersensation component of the CS measure created here may have driven the group differences effect, given that the greatest difference between groups was observed in aftersensations.
Several limitations should be considered when interpreting the current findings. First, while we attempted to match groups based on demographic characteristics, a significant age difference emerged. This difference may have impacted the current findings. Indeed, the knee OA good-sleeping group (the oldest group) exhibited the greatest TTS but the lowest aftersensation ratings to this task. Despite these limitations, our findings contribute additional evidence that insomnia is a significant pain-related issue. Compared to knee OA patients without insomnia, those with insomnia experience greater pain, depression, and pain-related catastrophizing. Participants with PI (non-knee OA) also experienced elevated depressive symptomatology and the poorest sleep quality. This is the first examination to our knowledge that demonstrates the interactive effect of catastrophizing and sleep duration on CS. While no causal pathways may be determined from this cross-sectional study, these data suggest that those with low sleep efficiency and higher catastrophizing have the greatest CS. Manipulations involving experimental sleep deprivation or restriction may be a useful next step in elucidating the underlying mechanisms by which catastrophizing and sleep shape the experience of pain. This preliminary work supports a promising line of inquiry in understanding the relationship between sleep and catastrophizing, 2 constructs known to have substantial impact in pain outcomes. Additional study is warranted to characterize the relationship between sleep, catastrophizing, and pain.
